Back to results
TerminatedPhase 3

A Study of Galantamine Used to Treat Patients With Mild to Moderate Alzheimer's Disease

NCT00679627

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Hradec Králové, Czechia

+94 additional locations

View on ClinicalTrials.gov
A Study of Galantamine Used to Treat Patients With Mild to Moderate Alzheimer's Disease — TrialFind